Response: Top tertile SFLC reduction indeed is an ...[Blood. 2008] - PubMed Result

Search for

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: Blood. 2008 Feb 15;111(4):2491. Links

Response: Top tertile SFLC reduction indeed is an independent feature of myeloma aggressiveness.

van Rhee F, Crowley J, Barlogie B.

PMID: 18263792 [PubMed - in process]

PMCID: PMC2234073 [Available on 02/15/09]

Related Articles

High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis. [Blood. 2007]
[Assessment of serum free light chain of patients with multiple myeloma and clinical significance thereof] [Zhonghua Yi Xue Za Zhi. 2007]
Light-chain removal by plasmapheresis in myeloma-associated renal failure. [Transfusion. 2007]
Treatment of multiple myeloma according to the extension of the disease: a prospective, randomised study comparing a less with a more aggressive cystostatic policy. Cooperative Group of Study and Treatment of Multiple Myeloma. [Br J Cancer. 1994]
Insulin resistance is associated with increased risk of major cardiovascular events in patients with preexisting coronary artery disease. [Am Heart J. 2007]
» See all Related Articles...

Display Show